Alaunos Therapeutics, Inc. Interest Income (Expense), Net
Alaunos Therapeutics, Inc. (TCRT) reported Interest Income (Expense), Net of -$444.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-08.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2021-11-08
- Alaunos Therapeutics, Inc. interest income (expense), net for the quarter ending 2021-09-30 was -$444.00K, a 6442.86% decline year-over-year.
- Alaunos Therapeutics, Inc. interest income (expense), net for the quarter ending 2020-09-30 was $7.00K.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 9 month |
|---|---|---|
| 2021-09-30 | -$444.00K 10-Q · filed 2021-11-08 | -$444.00K 10-Q · filed 2021-11-08 |
| 2020-09-30 | $7.00K 10-Q · filed 2021-11-08 | $412.00K 10-Q · filed 2021-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |